Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Intercontinental Exchange Inc. Common Stock (ICE) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance

Intercontinental Exchange Inc. Common StockTrade
Iovance Biotherapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Intercontinental Exchange Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Intercontinental Exchange Inc. Common Stock trades at $156.51 (market cap $87.21B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.18 (market cap $6.04B). The key difference: Intercontinental Exchange Inc. Common Stock is far larger — about 14.4× Iovance Biotherapeutics Inc. Common Stock's market cap, and Intercontinental Exchange Inc. Common Stock pays a 1.34% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals.

ICEIOVA
Market Cap
$87.21B$6.04B
Volume
2,029,11214,805,993
Sector
FinancialsHealth
52-Week High
$175.10$14.82
52-Week Low
$122.91$1.81
Enterprise Value
$105.12B$5.97B
Dividend Yield
1.34%—
Typical Hold Time
—0 Days

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

ICE

No sentiment data available yet.

IOVA
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Intercontinental Exchange Inc. Common Stock

Intercontinental Exchange provides technology and data services for financial institutions, corporations, and governments. Its businesses include exchanges and clearing, fixed-income data and analytics, and mortgage technology.

Read more on ICE →

About Iovance Biotherapeutics Inc. Common Stock

Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.

Read more on IOVA →